The 2023 Fiasp supply dramas are entering a new phase. We have an opportunity to contribute to the process in the next week. Scroll on and you’ll find details. But first, some background. Or jump ahead if you’re in a hurry…. History recap In June 2019 Fiasp was added to the Australian Pharmaceutical Benefits Scheme …
Friday the 31st of March is the last day you can get an Australian doctor to write a Fiasp script, which hopefully we can then get dispensed at PBS price up until the 1st of October 2023. I outlined this earlier this month in “A reprieve for Fiasp“. At least, that’s the current situation. Everyone’s hoping …
I’ve done articles like this in the past, comparing my clinical results over the years. But I’ve just hit what feels like another milestone, so I’m going to re-do it using my current reporting tools. I’m going to show data from four points in time: 2017, when I’d only recently started using an Automated Insulin …
Progressing through Hybrid and “Fully” Closed-looping Read More »
The sudden removal of the fast-acting Fiasp insulin from Australia’s PBS subsidy system has been a source of major heartache amongst the diabetes community. But we had a glimmer of hope this morning. The Federal Health Minister (Mark Butler MP) has announced that instead of Fiasp being summarily deleted from PBS, it’s going into “Supply …
I have a suspicion about some of the background to the current Fiasp drama, where Novo seems to have been pressured to remove Fiasp from PBS listing. Stories are rarely simple. I don’t know this is the complete story, but I’ll try to stick to recounting known facts! This is a potted history of one …
I’ve had a few people ask whether PBS was actually going to de-list Fiasp. None of us wanted it to be real. They have now quietly made the announcement, buried within the monthly list of changes.